<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0004338"><a href="http://purl.obolibrary.org/obo/MONDO_0004338">MONDO:0004338</a></h3>
<p><strong>Label:</strong> retinal cell cancer</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0008380">MONDO:0008380</a> (retinoblastoma),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_790">Orphanet:790</a>, <a href="http://purl.obolibrary.org/obo/OMIM_180200">OMIM:180200</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0009919">HP:0009919</a> (Retinoblastoma) 85.36%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0009919">HP:0009919</a> (Retinoblastoma) and <a href="http://purl.obolibrary.org/obo/HP_0100737">HP:0100737</a> (Abnormality of the hard palate) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0009919">HP:0009919</a> (Retinoblastoma) and <a href="http://purl.obolibrary.org/obo/HP_0030960">HP:0030960</a> (Abnormal pupillary morphology) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0009919">HP:0009919</a> (Retinoblastoma) and <a href="http://purl.obolibrary.org/obo/HP_0030506">HP:0030506</a> (Yellow/white lesions of the retina) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0009919">HP:0009919</a> (Retinoblastoma) and <a href="http://purl.obolibrary.org/obo/HP_0012254">HP:0012254</a> (Ewing's sarcoma) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0009919">HP:0009919</a> (Retinoblastoma) and <a href="http://purl.obolibrary.org/obo/HP_0011885">HP:0011885</a> (Hemorrhage of the eye) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0009919">HP:0009919</a> (Retinoblastoma) and <a href="http://purl.obolibrary.org/obo/HP_0011531">HP:0011531</a> (Vitritis) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0009919">HP:0009919</a> (Retinoblastoma) and <a href="http://purl.obolibrary.org/obo/HP_0011029">HP:0011029</a> (Internal hemorrhage) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0009919">HP:0009919</a> (Retinoblastoma) and <a href="http://purl.obolibrary.org/obo/HP_0011028">HP:0011028</a> (Abnormality of blood circulation) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0009919">HP:0009919</a> (Retinoblastoma) and <a href="http://purl.obolibrary.org/obo/HP_0011025">HP:0011025</a> (Abnormality of cardiovascular system physiology) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0009919">HP:0009919</a> (Retinoblastoma) and <a href="http://purl.obolibrary.org/obo/HP_0010987">HP:0010987</a> (Abnormality of cellular immune system) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0007902">HP:0007902</a> (Vitreous hemorrhage) and <a href="http://purl.obolibrary.org/obo/HP_0009919">HP:0009919</a> (Retinoblastoma) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0007862">HP:0007862</a> (Retinal calcification) and <a href="http://purl.obolibrary.org/obo/HP_0009919">HP:0009919</a> (Retinoblastoma) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and <a href="http://purl.obolibrary.org/obo/HP_0009919">HP:0009919</a> (Retinoblastoma) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004328">HP:0004328</a> (Abnormality of the anterior segment of the globe) and <a href="http://purl.obolibrary.org/obo/HP_0009919">HP:0009919</a> (Retinoblastoma) 75.00%</li>
</ul>
</body>
</html>
